低风险甲状腺癌的放射性碘消融治疗 - Suppr

Suppr

超能文献

Radioiodine ablation in low-risk thyroid cancer.

作者信息

Loo Suat W

出版信息

N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712.

DOI:10.1056/NEJMc1206712

PMID:22894583

Abstract

摘要

相似文献

Radioiodine ablation in low-risk thyroid cancer.

N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712.

Radioiodine ablation in low-risk thyroid cancer.

N Engl J Med. 2012 Aug 16;367(7):672; author reply 673-5. doi: 10.1056/NEJMc1206712.

Radioiodine ablation in low-risk thyroid cancer.

N Engl J Med. 2012 Aug 16;367(7):673; author reply 674. doi: 10.1056/NEJMc1206712.

Radioiodine for thyroid cancer--is less more?

N Engl J Med. 2012 May 3;366(18):1732-3. doi: 10.1056/NEJMe1202172.

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.

Thyroid cancer: successful remnant ablation-what is success?

Nat Rev Endocrinol. 2012 Sep;8(9):514-5. doi: 10.1038/nrendo.2012.113. Epub 2012 Jul 3.

Well-being after radiation therapy in thyroid cancer.

N Engl J Med. 2013 Feb 14;368(7):685-6. doi: 10.1056/NEJMc1212592.

[Current trends in treatment and follow-up of patients with differentiated thyroid carcinoma - experience with the use of recombinant human thyrotropin].

Vnitr Lek. 2013 Feb;59(2):106-12.

High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.

Thyroid. 2014 Mar;24(3):480-7. doi: 10.1089/thy.2013.0157. Epub 2014 Jan 17.

Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.

J Endocrinol Invest. 2012;35(6 Suppl):21-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Radioiodine ablation in low-risk thyroid cancer.

N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712.

Radioiodine ablation in low-risk thyroid cancer.

N Engl J Med. 2012 Aug 16;367(7):672; author reply 673-5. doi: 10.1056/NEJMc1206712.

Radioiodine ablation in low-risk thyroid cancer.

N Engl J Med. 2012 Aug 16;367(7):673; author reply 674. doi: 10.1056/NEJMc1206712.

Radioiodine for thyroid cancer--is less more?

N Engl J Med. 2012 May 3;366(18):1732-3. doi: 10.1056/NEJMe1202172.

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.

Thyroid cancer: successful remnant ablation-what is success?

Nat Rev Endocrinol. 2012 Sep;8(9):514-5. doi: 10.1038/nrendo.2012.113. Epub 2012 Jul 3.

Well-being after radiation therapy in thyroid cancer.

N Engl J Med. 2013 Feb 14;368(7):685-6. doi: 10.1056/NEJMc1212592.

[Current trends in treatment and follow-up of patients with differentiated thyroid carcinoma - experience with the use of recombinant human thyrotropin].

Vnitr Lek. 2013 Feb;59(2):106-12.

High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.

Thyroid. 2014 Mar;24(3):480-7. doi: 10.1089/thy.2013.0157. Epub 2014 Jan 17.

Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.

J Endocrinol Invest. 2012;35(6 Suppl):21-9.

Radioiodine ablation in low-risk thyroid cancer.

作者信息

Loo Suat W

出版信息

N Engl J Med. 2012 Aug 16;367(7):672-3; author reply 674. doi: 10.1056/NEJMc1206712.

DOI:10.1056/NEJMc1206712

PMID:22894583

Abstract

摘要